Nixon Peabody Trust’s Eli Lilly LLY Stock Holding History

Nixon Peabody Trust’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.5M	Sell	16,298 -697	-4%	-$712K	1.38%	18
2026 Q1	$15.6M	Sell	16,995 -1,527	-8%	-$1.55M	1.24%	20
2025 Q4	$19.9M	Sell	18,522 -1,036	-5%	-$991K	1.51%	16
2025 Q3	$14.9M	Buy	19,558 +48	+0.2%	+$35.7K	1.09%	28
2025 Q2	$15.2M	Buy	19,510 +7,588	+64%	+$5.9M	1.18%	27
2025 Q1	$9.85M	Buy	11,922 +1,443	+14%	+$1.2M	0.84%	41
2024 Q4	$8.09M	Buy	10,479 +8,125	+345%	+$6.73M	0.67%	44
2024 Q3	$2.09M	Sell	2,354 -11	-0.5%	-$9.89K	0.17%	59
2024 Q2	$2.14M	Hold	2,365	–	–	0.19%	57
2024 Q1	$1.84M	Buy	2,365 +575	+32%	+$409K	0.17%	57
2023 Q4	$1.04M	Buy	1,790 +1,390	+348%	+$811K	0.12%	66
2023 Q3	$215K	Buy	+400	New	+$206K	0.18%	73
2017 Q1	–	Sell	-5,000	Closed	-$368K	–	67
2016 Q4	$368K	Sell	5,000 -2,800	-36%	-$209K	0.36%	61
2016 Q3	$626K	Hold	7,800	–	–	0.61%	53
2016 Q2	$614K	Hold	7,800	–	–	0.53%	62
2016 Q1	$562K	Hold	7,800	–	–	0.5%	64
2015 Q4	$657K	Buy	+7,800	New	+$647K	0.6%	60

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nixon Peabody Trust's LLY Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Eli Lilly (LLY) stake by 4.1% in Q2 2026, selling an estimated $712K and leaving 16,298 shares worth $19.5M. The position accounts for 1.38% of the portfolio, ranked #18.

Nixon Peabody Trust first reported a position in LLY in Q4 2015 and has held it in 17 quarters since. The position peaked at $19.9M in Q4 2025. 1,844 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Nixon Peabody Trust held 16,298 shares of Eli Lilly worth $19.5M as of Q2 2026.
Nixon Peabody Trust sold 697 Eli Lilly shares in Q2 2026, an estimated $712K.
Eli Lilly made up 1.38% of Nixon Peabody Trust's portfolio in Q2 2026, its #18 holding.
Nixon Peabody Trust first reported a position in Eli Lilly in Q4 2015 and has held it in 17 quarters since.
Nixon Peabody Trust's Eli Lilly position peaked at $19.9M in Q4 2025.
1,844 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.